This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation
September 2026
Boston, United States

Joanne Hsieh, PhD
Head of Metabolism at Gordian Biotechnology
Speaker

Profile

Joanne Hsieh, PhD leads Gordian Biotechnology's Metabolism program, which encompasses novel target discovery and development efforts in adipose- and liver-related indications. Joanne did her PhD work on the glucagon-like peptides with Khosrow Adeli and Daniel Drucker at the University of Toronto. Her postdoctoral training was with Alan Tall at Columbia University. Over the course of her scientific career, Joanne has investigated atherosclerosis, dyslipidemia, diabetes, metabolic dysfunction-associated steatohepatitis, and obesity. She has first author publications in pre-eminent journals including Gastroenterology, Journal of Hepatology, and Nature. Joanne was also a cofounder of Fortico Biotech, which developed small molecules to tackle MASH.

Agenda Sessions

  • High-throughput in vivo screening to discover novel targets for adipose-directed therapies

    11:10